Meticulous Research®, a leading market research company, has published a report titled ‘Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, Lyophilized) Type (Live Attenuated, mRNA, Inactivated) Virus (Adenovirus, Retrovirus, Plasmid DNA, AAV), Approach, Indication, Application, Packaging—Global Forecast to 2031.’ According to this report, the viral vaccines market is expected to reach $47.01 billion by 2031, growing at a CAGR of 1.9% from 2024 to 2031. This growth is attributed to a robust product pipeline, increasing government focus on immunization, advancements in vaccine administration technologies, the use of inactivated vaccines in treatments, and the expansion of biopharmaceutical production capacities. Additionally, a rising emphasis on therapeutic vaccines, greater use of adjuvants, opportunities in emerging markets, and the development of stable, energy-efficient ultra-low temperature freezers are anticipated to further enhance market prospects.